References Gu Y, Guo Y, Gao N, et al. The proteomic characterization of the peritumormicroenvironment in human hepatocellular carcinoma[J]. Oncogene. 2022;41:2480–91. Article CAS PubMed PubMed Central Google Scholar de Castria TB, Khalil DN, Harding JJ, et al. Tremelimumab and durvalumab in the treatment of unresectable, advanced hepatocellular carcinoma[J]. Future Oncol. 2022;18:3769–82. Article PubMed Google Scholar Broadfield LA, Duarte JAG, Schmieder R, et al.